Joel Greenblatt's position in Ionis Pharmaceuticals is currently worth $202 Thousand. That's 0.00% of their equity portfolio (1265th largest holding). The first Ionis Pharmaceuticals trade was made in Q4 2016. Since then Joel Greenblatt bought shares ten more times and sold shares on thirteen occasions. The investor's estimated purchase price is $237 Thousand, resulting in a loss of 15%.